Atossa Genetics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $18 |
Gross Profit | -4 | -5 | |
EBITDA | -6,381 | -7,101 | -6,975 |
EBIT | -6,385 | -7,105 | -6,980 |
Net Income | -7,230 | -6,049 | -5,878 |
Net Change In Cash | 0 | 0 | 18 |
Free Cash Flow | -4,760 | -4,534 | -4,704 |
Cash | 74,766 | 79,526 | 84,070 |
Basic Shares | 125,772 | 125,732 | 125,319 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -23 | -8 | -23 | -46 |
EBITDA | -31,354 | -27,683 | -20,498 | -14,560 |
EBIT | -31,377 | -27,691 | -20,521 | -14,606 |
Net Income | -30,094 | -26,229 | -20,606 | -21,099 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -25,487 | 96,823 | 26,972 | |
Free Cash Flow | -20 | -20,787 | -16,481 | -11,579 |
Cash | 88,460 | 110,890 | 136,377 | 39,553 |
Basic Shares | 126,081 | 126,624 | 116,950 | 11,308 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.05 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.05 |
2023-12-31 | -$0.09 |
